| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| KfW | 50.1% | $384M | 113M | KfW | Aug 1, 2025 | |||
| dievini Hopp BioTech holding GmbH & Co KG | 36.7% | $280M | 82.4M | Dietmar Hopp | Jun 12, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 19.6M | $105M | +$42.9M | $5.39 | 92 |
| 2025 Q2 | 11.5M | $62.5M | +$21.4M | $5.43 | 89 |
| 2025 Q1 | 7.87M | $21.8M | -$778K | $2.77 | 81 |
| 2024 Q4 | 7.86M | $26.6M | -$5.83M | $3.41 | 74 |
| 2024 Q3 | 11.1M | $32.8M | -$7.06M | $2.94 | 78 |
| 2024 Q2 | 14.1M | $48M | +$6.61M | $3.40 | 84 |
| 2024 Q1 | 2.03M | $6.15M | -$21.3M | $3.03 | 9 |
| 2023 Q4 | 257K | $1.08M | +$452K | $4.21 | 2 |
| 2023 Q3 | 33.2M | $226M | -$14.8M | $6.83 | 82 |
| 2023 Q2 | 35.2M | $367M | -$7.76M | $10.42 | 84 |
| 2023 Q1 | 36.7M | $256M | +$176M | $6.97 | 81 |
| 2022 Q4 | 11.6M | $70M | +$25.6M | $6.03 | 78 |
| 2022 Q3 | 7.04M | $55.5M | -$14.6M | $7.88 | 69 |
| 2022 Q2 | 8.36M | $113M | -$93.4M | $13.61 | 74 |
| 2022 Q1 | 14.4M | $283M | -$10M | $19.61 | 102 |
| 2021 Q4 | 14.6M | $503M | +$23.3M | $34.31 | 99 |
| 2021 Q3 | 13.7M | $749M | -$12.7M | $54.62 | 103 |
| 2021 Q2 | 10.7M | $789M | -$28.4M | $73.48 | 102 |
| 2021 Q1 | 14.1M | $1.28B | +$338M | $91.46 | 83 |
| 2020 Q4 | 7.25M | $588M | -$18.6M | $81.07 | 57 |
| 2020 Q3 | 7.61M | $355M | +$354M | $46.55 | 42 |
| 2020 Q2 | 108 | $8K | $0 | $74.07 | 1 |
| 2020 Q1 | 108 | $8K | $0 | $74.07 | 1 |
| 2019 Q4 | 108 | $8K | $0 | $74.07 | 1 |
| 2019 Q3 | 108 | $8K | $0 | $74.07 | 1 |
| 2019 Q2 | 108 | $8K | $0 | $74.07 | 1 |
| 2019 Q1 | 108 | $8K | $0 | $74.07 | 1 |